The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Jochen Graff

Pharmazentrum Frankfurt/ZAFES

Institute of Clinical Pharmacology

University Hospital

Frankfurt/Main

Germany

[email]@em.uni-frankfurt.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, University Hospital, Frankfurt/Main, Germany. 2001 - 2007
  • Pharmazentrum Frankfurt/ZAFES(Center of Drug Research, Development, and Safety), Institute of Clinical Pharmacology, Germany. 2007

References

  1. Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity. Graff, J., von Hentig, N., Misselwitz, F., Kubitza, D., Becka, M., Breddin, H.K., Harder, S. J. Clin. Pharmacol (2007) [Pubmed]
  2. Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study. Graff, J., Arabmotlagh, M., Cheung, R., Geisslinger, G., Harder, S. Clin. Ther (2007) [Pubmed]
  3. Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents. Graff, J., Harder, S. Semin. Thromb. Hemost. (2005) [Pubmed]
  4. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. Graff, J., Harder, S., Wahl, O., Scheuermann, E.H., Gossmann, J. Clin. Pharmacol. Ther. (2005) [Pubmed]
  5. Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators. Graff, J., Klinkhardt, U., Harder, S. Thromb. Res. (2004) [Pubmed]
  6. Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans. Graff, J., Klinkhardt, U., Westrup, D., Kirchmaier, C.M., Breddin, H.K., Harder, S. Br. J. Clin. Pharmacol (2003) [Pubmed]
  7. Immunosuppressive therapy regimen and platelet activation in renal transplant patients. Graff, J., Klinkhardt, U., Harder, S., Wegert, W., Lenz, T., Scheuermann, E.H., Gossmann, J. Clin. Pharmacol. Ther. (2002) [Pubmed]
  8. Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximab. Graff, J., Andries, D., Elsner, M., Westrup, D., Bassus, S., Franz, N., Klinkhardt, U., Harder, S. Br. J. Clin. Pharmacol (2001) [Pubmed]
 
WikiGenes - Universities